Related references
Note: Only part of the references are listed.Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
Dawei Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
New perspectives in the therapy of chronic hepatitis B
Pietro Lampertico et al.
GUT (2012)
In Vitro Epsilon RNA-Dependent Protein Priming Activity of Human Hepatitis B Virus Polymerase
Scott A. Jones et al.
JOURNAL OF VIROLOGY (2012)
Selection of chronic hepatitis B therapy with high barrier to resistance
Robert Gish et al.
LANCET INFECTIOUS DISEASES (2012)
The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication
Gaetan Billioud et al.
ANTIVIRAL RESEARCH (2011)
Phenylpropenamide derivatives: Anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs
Peiyuan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion
Wenquan Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Indoleamine 2,3-Dioxygenase Mediates the Antiviral Effect of Gamma Interferon against Hepatitis B Virus in Human Hepatocyte-Derived Cells
Richeng Mao et al.
JOURNAL OF VIROLOGY (2011)
The Arginine Clusters of the Carboxy-Terminal Domain of the Core Protein of Hepatitis B Virus Make Pleiotropic Contributions to Genome Replication
Eric B. Lewellyn et al.
JOURNAL OF VIROLOGY (2011)
Serine Phosphoacceptor Sites within the Core Protein of Hepatitis B Virus Contribute to Genome Replication Pleiotropically
Eric B. Lewellyn et al.
PLOS ONE (2011)
Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly Accelerators
Sarah P. Katen et al.
ACS CHEMICAL BIOLOGY (2010)
Current status and challenges of antiretroviral research and therapy
Jose A. Este et al.
ANTIVIRAL RESEARCH (2010)
Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Chunxiao Xu et al.
JOURNAL OF VIROLOGY (2010)
Management of Chronic Hepatitis B: Status and Challenges beyond Treatment Guidelines
Johannes Wiegand et al.
SEMINARS IN LIVER DISEASE (2010)
Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries
Sheikh Mohammad Fazle Akbar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Fabien Zoulim et al.
GASTROENTEROLOGY (2009)
Benefits and Risks of Nucleoside Analog Therapy for Hepatitis B
Jules L. Dienstag
HEPATOLOGY (2009)
Special Populations with Hepatitis B Virus Infection
Marion G. Peters
HEPATOLOGY (2009)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia
Yun-Fan Liaw
JOURNAL OF HEPATOLOGY (2009)
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Hepatitis B viruses: Reverse transcription a different way
Michael Nassal
VIRUS RESEARCH (2008)
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion
Anne Marie Dougherty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: An intermediate of covalently closed circular DNA formation
Haitao Guo et al.
JOURNAL OF VIROLOGY (2007)
The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
J. J. Feld et al.
ANTIVIRAL RESEARCH (2007)
Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays
Tianlun Zhou et al.
ANTIVIRAL RESEARCH (2006)
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stephen J. Stray et al.
JOURNAL OF MOLECULAR RECOGNITION (2006)
Hepatitis B virus reverse transcriptase and ε RNA sequences required for specific interaction in vitro
JM Hu et al.
JOURNAL OF VIROLOGY (2006)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids
DH Perlman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
SJ Stray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Epidemiology and natural history of hepatitis B
BJ McMahon
SEMINARS IN LIVER DISEASE (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro
WE Delaney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
DJ Tenney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA
J Köck et al.
JOURNAL OF VIROLOGY (2004)
Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function
JM Hu et al.
JOURNAL OF VIROLOGY (2004)
Prevention of hepatitis B virus-related hepatocellular carcinoma
ASF Lok
GASTROENTEROLOGY (2004)
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
K Deres et al.
SCIENCE (2003)
Conditional replication of duck hepatitis B virus in hepatoma cells
JT Guo et al.
JOURNAL OF VIROLOGY (2003)
The 113th and 117th charged amino acids in the 5th alpha-helix of the HBV core protein are necessary for pgRNA encapsidation
SM Lee et al.
VIRUS GENES (2003)
Antiviral activities and cellular toxicities of modified 2′,3′-dideoxy-2′,3′-didehydrocytidine analogues
LJ Stuyver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro
WE Delaney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro
S Levine et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins
JM Hu et al.
JOURNAL OF VIROLOGY (2002)
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections
TL Zhou et al.
JOURNAL OF VIROLOGY (2000)
Hepatitis B virus biology
C Seeger et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Share Paper
